Top Stories
-
Six Columbia University scientists have received NIH High-Risk, High-Reward grants that are given to exceptionally creative scientists proposing unconventional, but potentially high-impact, research
-
A public battle rages over access to experimental, trial-phase drugs
Topic
-
Lou Gehrig’s worst full season was his best as amyotrophic lateral sclerosis, or ALS, was beginning to erode him from the inside.
Topic
-
Source:
BLOOMBERG NEWSNeil Shneider, Stockman-Mauriello’s doctor and director of the Eleanor and Lou Gehrig ALS Center at Columbia University in New York, nonetheless asked Biogen for access.
